The SYNTAX Score is a tool developed in connection with the SYNTAX Trial, a trial comparing PCI and Cardiac Surgery in complex, high-risk LM and/or 3VD patients. It is important to note that the safety and effectiveness of drug-eluting stents have not been established in these high risk patients, and physicians are strongly encouraged to review the indications, contraindications, warnings and instructions included in the products' Directions for Use.
The SYNTAX Score and related materials are not intended to provide medical advice or guidance as to appropriate treatment strategies for individual patients. Risks and benefits should be carefully considered for each patient taking into account all available data and treatment options and physicians and other healthcare providers should always exercise their own clinical judgment for any given situation. In cases where SYNTAX Score and related materials are relevant to the diagnosis, prevention or treatment of medical conditions which can also be diagnosed, prevented or treated by any products, physicians and other healthcare providers must take care to always follow individual product instructions for use in order to ensure safe use and that the products intended performance(s) is/are achieved. Physicians and other healthcare providers are therefore cautioned that such tools are not intended to supersede individual product instructions for use in any way.
The Syntax Score and related materials were developed under the direction of the SYNTAX Steering Committee, and was made possible by support from Boston Scientific Corporation and Cardialysis BV.